{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:13:42Z","timestamp":1776132822223,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["heartlungcirc.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.hlc.2017.10.020","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T00:30:39Z","timestamp":1511224239000},"page":"443-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Proton Pump Inhibitors and Cardiovascular Events: A Systematic Review"],"prefix":"10.1016","volume":"27","author":[{"given":"Timothy P.","family":"Shiraev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Bullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2017.10.020_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131558","article-title":"PPI versus histamine H2 receptor antagonists for prevention of upper gastrointestinal injury associated with low-dose aspirin: systematic review and meta-analysis","volume":"10","author":"Mo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.hlc.2017.10.020_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124653","article-title":"Proton pump inhibitor usage and the risk of myocardial infarction in the general population","volume":"10","author":"Shah","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.hlc.2017.10.020_bib0015","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/CIRCULATIONAHA.111.032912","article-title":"Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial","volume":"125","author":"Goodman","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2017.10.020_bib0020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2009.261","article-title":"Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome","volume":"301","author":"Ho","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2017.10.020_bib0025","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1503\/cmaj.082001","article-title":"A population-based study of the drug interaction between proton pump inhibitors and clopidogrel","volume":"180","author":"Juurlink","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.hlc.2017.10.020_bib0030","series-title":"FDA announces new warning on plavix: avoid use with prilosec\/prilosec OTC","author":"FDA","year":"2009"},{"key":"10.1016\/j.hlc.2017.10.020_bib0035","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/heartjnl-2012-302371","article-title":"Concomitant use of clopidogrel and proton pump inhibitors: impact on platelet function and clinical outcome\u2014a systematic review","volume":"99","author":"Focks","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.hlc.2017.10.020_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d2690","article-title":"Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study","volume":"342","author":"Charlot","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.hlc.2017.10.020_bib0045","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/jamainternmed.2013.2851","article-title":"Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals","volume":"173","author":"Maggio","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.hlc.2017.10.020_bib0050","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1161\/CIRCRESAHA.116.308807","article-title":"Proton pump inhibitors accelerate endothelial senescence","volume":"118","author":"Yepuri","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.hlc.2017.10.020_bib0055","doi-asserted-by":"crossref","first-page":"939","DOI":"10.18553\/jmcp.2016.22.8.939","article-title":"Clopidogrel-proton pump inhibitor drug-drug interaction and risk of adverse clinical outcomes among PCI-treated ACS patients: a meta-analysis","volume":"22","author":"Serbin","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.hlc.2017.10.020_bib0060","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002245","article-title":"Individual proton pump inhibitors and outcomes in patients with coronary artery disease on dual antiplatelet therapy: a systematic review","volume":"4","author":"Sherwood","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hlc.2017.10.020_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12872-016-0453-6","article-title":"Is the concomitant use of clopidogrel and Proton Pump Inhibitors still associated with increased adverse cardiovascular outcomes following coronary angioplasty?: a systematic review and meta-analysis of recently published studies (2012\u20132016)","volume":"17","author":"Bundhun","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.hlc.2017.10.020_bib0070","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/1074248416663647","article-title":"Combination use of clopidogrel and proton pump inhibitors increases major adverse cardiovascular events in patients with coronary artery disease: a meta-Analysis","volume":"22","author":"Niu","year":"2017","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.hlc.2017.10.020_bib0075","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.12926","article-title":"Proton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis","volume":"29","author":"Sun","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.hlc.2017.10.020_bib0080","doi-asserted-by":"crossref","first-page":"228","DOI":"10.23736\/S0391-1977.16.02571-2","article-title":"Concomitant use of proton pump inhibitors and dual antiplatelet therapy for cardiovascular outcomes","volume":"42","author":"Mandurino-Mirizzi","year":"2017","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.hlc.2017.10.020_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084890","article-title":"Proton pump inhibitors and the risk of adverse cardiac events","volume":"8","author":"Juurlink","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.hlc.2017.10.020_bib0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00228-014-1779-6","article-title":"Revising the link between proton-pump inhibitors and risk of acute myocardial infarction-a case-crossover analysis","volume":"71","author":"Turkiewicz","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.hlc.2017.10.020_bib0095","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.amjmed.2016.03.042","article-title":"Efficacy and safety of proton-pump inhibitors in high-risk cardiovascular subsets of the COGENT trial","volume":"129","author":"Vaduganathan","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.hlc.2017.10.020_bib0100","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","article-title":"Executive summary: heart disease and stroke statistics\u20142014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2017.10.020_bib0105","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.hlc.2017.10.020_bib0110","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence\u2014study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.hlc.2017.10.020_bib0115","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijcard.2014.09.036","article-title":"Proton pump inhibitor use represents an independent risk factor for myocardial infarction","volume":"177","author":"Shih","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2017.10.020_bib0120","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/1538574412457081","article-title":"Clinical significance of the clopidogrel-proton pump inhibitor interaction after peripheral endovascular intervention for claudication","volume":"46","author":"Meltzer","year":"2012","journal-title":"Vasc Endovasc Surg"},{"key":"10.1016\/j.hlc.2017.10.020_bib0125","series-title":"Mechanisms of vascular disease: a reference book for vascular specialists","author":"Fitridge","year":"2011"},{"key":"10.1016\/j.hlc.2017.10.020_bib0130","series-title":"Clopidogrel therapy and CYP 2C19 genotype. Medical genetics summaries","author":"Dean","year":"2012"},{"key":"10.1016\/j.hlc.2017.10.020_bib0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5056\/jnm.2013.19.1.25","article-title":"Pharmacokinetics and pharmacodynamics of the proton pump inhibitors","volume":"19","author":"Shin","year":"2013","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.hlc.2017.10.020_bib0140","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.3748\/wjg.v18.i18.2161","article-title":"Clopidogrel and proton pump inhibitors\u2014where do we stand in 2012?","volume":"18","author":"Drepper","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hlc.2017.10.020_bib0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12664-016-0645-0","article-title":"Proton pump inhibitors and other disease-based factors in the recurrence of adverse cardiovascular events following percutaneous coronary angiography: a long-term cohort","volume":"35","author":"Ayub","year":"2016","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.hlc.2017.10.020_bib0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ehjcvp\/pvv036","article-title":"Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events","volume":"2","author":"Fortuna","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.hlc.2017.10.020_bib0155","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.113.003602","article-title":"Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine","volume":"128","author":"Ghebremariam","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2017.10.020_bib0160","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1161\/CIRCULATIONAHA.114.009343","article-title":"Response to letters regarding article, \u201cUnexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine\u201d","volume":"129","author":"Ghebremariam","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2017.10.020_bib0165","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/01.CIR.0000085067.55901.89","article-title":"Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine","volume":"108","author":"St\u00fchlinger","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2017.10.020_bib0170","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1161\/CIRCULATIONAHA.113.005585","article-title":"Letter by Montenegro and Lundberg regarding article, \u201cUnexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine\u201d","volume":"129","author":"Montenegro","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2017.10.020_bib0175","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.redox.2016.08.001","article-title":"Omeprazole impairs vascular redox biology and causes xanthine oxidoreductase-mediated endothelial dysfunction","volume":"9","author":"Pinheiro","year":"2016","journal-title":"Redox Biol"},{"key":"10.1016\/j.hlc.2017.10.020_bib0180","article-title":"Effects of CYP2C19 loss-of-function variants on the eradication of H. pylori infection in patients treated with proton pump inhibitor-based triple therapy regimens: a meta-analysis of randomized clinical trials","volume":"8","author":"Tang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.hlc.2017.10.020_bib0185","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1536\/ihj.16-208","article-title":"Potential cardiovascular risks of proton pump inhibitors in the general population","volume":"58","author":"Zhu","year":"2017","journal-title":"Int Heart J"},{"key":"10.1016\/j.hlc.2017.10.020_bib0190","doi-asserted-by":"crossref","first-page":"e637S","DOI":"10.1378\/chest.11-2306","article-title":"Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Vandvik","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2017.10.020_bib0195","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40265-017-0712-6","article-title":"The safety of appropriate use of over-the-counter proton pump inhibitors: an evidence-based review and Delphi consensus","volume":"77","author":"Johnson","year":"2017","journal-title":"Drugs"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950617314671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950617314671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T18:48:56Z","timestamp":1659898136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950617314671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1443950617314671"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2017.10.020","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton Pump Inhibitors and Cardiovascular Events: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2017.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2017 Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). All rights reserved.","name":"copyright","label":"Copyright"}]}}